Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Seattle Genetics shares drop 13% on news of FDA holds on several early-stage clinical trials
Seattle Genetics shares drop 13% on news of FDA holds on several early-stage clinical trials
Seattle Genetics shares drop 13% on news of FDA holds on several early-stage clinical trials
Submitted by
admin
on December 27, 2016 - 1:47pm
Source:
Marketwatch
News Tags:
Seattle Genetics
FDA
vadastuximab talirine
acute myeloid leukemia
Headline:
Seattle Genetics shares drop 13% on news of FDA holds on several early-stage clinical trials
Do Not Allow Advertisers to Use My Personal information
